Published in J Am Soc Nephrol on January 03, 2007
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function. Int J Vasc Med (2012) 0.97
Oxidative stress, endothelial function, carotid artery intimal thickness and their correlates among chronic peritoneal dialysis patients. Indian J Nephrol (2011) 0.83
Arterial Stiffness Gradient. Pulse (Basel) (2015) 0.79
Whole blood viscosity extrapolation formula: Note on appropriateness of units. N Am J Med Sci (2011) 0.79
Abnormal blood rheology and chronic low grade inflammation: possible risk factors for accelerated atherosclerosis and coronary artery disease in Lewis negative subjects. Atherosclerosis (2015) 0.77
Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia. N Am J Med Sci (2010) 0.77
Exploring the Relationships between Hemoglobin, the Endothelium and Vascular Health in Patients with Chronic Kidney Disease. Nephron Extra (2011) 0.76
Ambulatory arterial stiffness index is higher in hypertensive patients with chronic kidney disease. Int J Hypertens (2012) 0.76
Relationship between kidney disease and endothelial function in peripheral artery disease. J Vasc Surg (2014) 0.75
Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study. J Am Heart Assoc (2016) 0.75
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15
Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke (2003) 4.10
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol (2007) 3.41
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36
Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension (2005) 3.27
Central pulse pressure and mortality in end-stage renal disease. Hypertension (2002) 3.02
Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens (2012) 2.71
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension (2009) 2.58
Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol (2010) 2.54
Arterial stiffness and kidney function. Hypertension (2004) 2.45
Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation (2002) 2.44
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Structural and genetic bases of arterial stiffness. Hypertension (2005) 2.31
Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int (2003) 2.21
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol (2005) 2.20
Fibromuscular dysplasia. Orphanet J Rare Dis (2007) 2.18
Role of modifiable risk factors in life expectancy in the elderly. J Hypertens (2005) 2.09
Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension (2005) 2.08
Aortic stiffness measurement improves the prediction of asymptomatic coronary artery disease in stroke/transient ischemic attack patients. Int J Stroke (2013) 2.07
Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens (2005) 2.04
Unknown complication of arterial switch operation: resistant hypertension induced by a strong aortic arch angulation. Circulation (2013) 2.02
Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens (2011) 1.89
Individual/neighborhood social factors and blood pressure in the RECORD Cohort Study: which risk factors explain the associations? Hypertension (2010) 1.74
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol (2008) 1.62
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens (2012) 1.59
Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension (2007) 1.59
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation (2002) 1.58
Carotid and aortic stiffness: determinants of discrepancies. Hypertension (2006) 1.56
Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol (2007) 1.49
Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging. JACC Cardiovasc Imaging (2011) 1.48
Influence of sex on the relation between heart rate and aortic stiffness. J Hypertens (2003) 1.48
Associations of supermarket characteristics with weight status and body fat: a multilevel analysis of individuals within supermarkets (RECORD study). PLoS One (2012) 1.47
True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence. J Hypertens (2015) 1.47
Genetic influences on the arterial wall. Clin Exp Pharmacol Physiol (2007) 1.47
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach. J Hypertens (2013) 1.46
Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens (2009) 1.44
Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies. Hypertension (2012) 1.44
Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension (2012) 1.43
Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens (2005) 1.42
Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int (2012) 1.38
Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol (2005) 1.37
Arterial remodeling associates with CKD progression. J Am Soc Nephrol (2011) 1.32
Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int (2004) 1.30
Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens (2004) 1.29
An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens (2010) 1.26
Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension (2009) 1.25
Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J (2012) 1.21
Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 1.20
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care (2007) 1.16
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis (2005) 1.15
Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 1.15
Cohort profile: residential and non-residential environments, individual activity spaces and cardiovascular risk factors and diseases--the RECORD Cohort Study. Int J Epidemiol (2011) 1.15
Sex difference in cardiovascular risk: role of pulse pressure amplification. J Am Coll Cardiol (2012) 1.15
In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension (2007) 1.12
Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens (2013) 1.12
Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant (2011) 1.11
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens (2004) 1.10
Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension (2009) 1.10
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis (2009) 1.09
Reference values for central blood pressure. J Am Coll Cardiol (2014) 1.08
Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08
[Diabetes and socio-economic deprivation. A study in a large French population]. Bull Acad Natl Med (2008) 1.07
Distance measurements for the assessment of carotid to femoral pulse wave velocity. J Hypertens (2009) 1.06
Foot detection and distances by different methods: implications for pulse wave velocity values. J Hypertens (2015) 1.06
Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens (2002) 1.06
All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol (2008) 1.05
Large-vessel correlates of cerebral small-vessel disease. Neurology (2013) 1.04
Arterial functions: how to interpret the complex physiology. Nephrol Dial Transplant (2010) 1.04
Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J Ultrasound Med (2010) 1.04
Aortic stiffness as a tissue biomarker for predicting future cardiovascular events in asymptomatic hypertensive subjects. Ann Med (2012) 1.03
Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl (2003) 1.03
Risk assessment for severe clinical attachment loss in an adult population. J Periodontol (2006) 1.03
Arterial stiffness as surrogate end point: needed clinical trials. Hypertension (2012) 1.02
Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol (2012) 1.02
Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol Dial Transplant (2012) 1.02
Characterization of arterial wall mechanical behavior and stresses from human clinical data. J Biomech (2008) 1.01
Impact of age on glomerular filtration estimates. Nephrol Dial Transplant (2008) 1.01
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol (2011) 1.01